Update on the epidemiology of carbapenemases in Latin America and the Caribbean

Expert Rev Anti Infect Ther. 2021 Feb;19(2):197-213. doi: 10.1080/14787210.2020.1813023. Epub 2020 Sep 11.

Abstract

Introduction: Carbapenemases are β-lactamases able to hydrolyze a wide range of β-lactam antibiotics, including carbapenems. Carbapenemase production in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., with and without the co-expression of other β-lactamases is a serious public health threat. Carbapenemases belong to three main classes according to the Ambler classification: class A, class B, and class D.

Areas covered: Carbapenemase-bearing pathogens are endemic in Latin America. In this review, we update the status of carbapenemases in Latin America and the Caribbean.

Expert opinion: Understanding the current epidemiology of carbapenemases in Latin America and the Caribbean is of critical importance to improve infection control policies limiting the dissemination of multi-drug-resistant pathogens and in implementing appropriate antimicrobial therapy.

Keywords: Acinetobacter baumannii; Klebsiella pneumoniae; Pseudomonas aeruginosa; Latin America; carbapenem resistance; carbapenem-resistant Enterobacterales (CRE); carbapenemases; carbapenems.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / classification
  • Bacterial Proteins / metabolism*
  • Caribbean Region / epidemiology
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacteria / drug effects
  • Gram-Negative Bacteria / enzymology*
  • Gram-Negative Bacterial Infections / epidemiology*
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Latin America / epidemiology
  • beta-Lactamases / classification
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • beta-Lactamases
  • carbapenemase